Breast cancer is the most malignant tumor in women, and there is no absolute cure for it.
Although treatment modalities including surgery, chemotherapy, and radiotherapy are …

(1) Although long noncoding RNAs (lncRNAs) are known to be precursors of microRNAs
(miRNAs), they frequently act as competing endogoneous RNAs (ceRNAs), yet still their …

Among patients with triple-negative breast cancer (TNBC), distant metastasis is the leading
cause of death. Our previous studies have shown that TNBC progression is greatly …

The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …

The long non-coding RNAs (lncRNAs) have been implicated in multiple human cancers,
which may offer great potential as putative targets for cancer diagnosis and treatment …

Cancer drug resistance remains a formidable challenge in modern oncology, necessitating
innovative therapeutic strategies. The convergence of intricate regulatory networks involving …

Abstract The PI3K/Akt signalling pathway is associated with the occurrence and
development of tumours and significantly affects the prognosis of patients. We established a …

Tumor metastasis is the main reason for cancer-related death, but there is still a lack of
effective therapeutic to inhibit tumor metastasis. Therefore, the discovery and study of new …

Breast cancer (BC) represents aggressive cancer affecting most women's lives globally.
Metastasis and recurrence are the two most common factors in a breast cancer patient's …

Simple Summary Aldehyde dehydrogenase 1A3 (ALDH1A3) is the primary cause of the high
ALDH activity associated with cancer stem cell (CSC) populations in multiple cancers and its …